Original Article
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
Translational Lung Cancer Research
2021;
10
(4)
:1594-1607
.
(29 April 2021)
Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance—a novel technique and initial experience with 30 cases
Translational Lung Cancer Research
2021;
10
(4)
:1608-1622
.
(29 April 2021)
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib
Translational Lung Cancer Research
2021;
10
(4)
:1623-1634
.
(29 April 2021)
Is flexible bronchoscopy necessary in the preoperative workup of patients with peripheral cT1N0 subsolid lung cancer? —a prospective multi-center cohort study
Translational Lung Cancer Research
2021;
10
(4)
:1635-1641
.
(29 April 2021)
Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study
Translational Lung Cancer Research
2021;
10
(4)
:1642-1652
.
(29 April 2021)
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1653-1665
.
(29 April 2021)
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(4)
:1666-1678
.
(29 April 2021)
Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry
Translational Lung Cancer Research
2021;
10
(4)
:1679-1689
.
(29 April 2021)
A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy
Translational Lung Cancer Research
2021;
10
(4)
:1690-1699
.
(29 April 2021)
Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2021;
10
(4)
:1700-1710
.
(29 April 2021)
Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodules
Translational Lung Cancer Research
2021;
10
(4)
:1711-1719
.
(29 April 2021)
Age at first birth and lung cancer: a two-sample Mendelian randomization study
Translational Lung Cancer Research
2021;
10
(4)
:1720-1733
.
(29 April 2021)
Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1734-1746
.
(29 April 2021)
Distinct patterns of somatic genomic alterations and mutational signatures in central and peripheral-type small-cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1747-1760
.
(29 April 2021)
Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations
Translational Lung Cancer Research
2021;
10
(4)
:1761-1772
.
(29 April 2021)
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1773-1791
.
(29 April 2021)
Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung
Translational Lung Cancer Research
2021;
10
(4)
:1792-1803
.
(29 April 2021)
Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1804-1818
.
(29 April 2021)
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study
Translational Lung Cancer Research
2021;
10
(4)
:1819-1828
.
(29 April 2021)
Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery
Translational Lung Cancer Research
2021;
10
(4)
:1829-1840
.
(29 April 2021)
Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(4)
:1841-1856
.
(29 April 2021)
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma
Translational Lung Cancer Research
2021;
10
(4)
:1857-1872
.
(29 April 2021)
Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancer in vitro and in vivo
Translational Lung Cancer Research
2021;
10
(4)
:1873-1888
.
(29 April 2021)
Review Article
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Translational Lung Cancer Research
2021;
10
(4)
:1889-1916
.
(29 April 2021)
Case Report
Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen
Translational Lung Cancer Research
2021;
10
(4)
:1917-1923
.
(29 April 2021)
Editorial Commentary
From CheckMate 227 to CheckMate 9LA: rethinking the status of chemotherapy in the immunotherapy era—chemo-free or chemo-reform?
Translational Lung Cancer Research
2021;
10
(4)
:1924-1927
.
(29 April 2021)
Editorial on Radiotherapy in Thoracic Malignancies1
Radiotherapy in thoracic malignancies: the preface
Translational Lung Cancer Research
2021;
10
(4)
:1928-1929
.
(29 April 2021)
Review Article on Radiotherapy in Thoracic Malignancies1
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
Translational Lung Cancer Research
2021;
10
(4)
:1930-1949
.
(29 April 2021)
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question
Translational Lung Cancer Research
2021;
10
(4)
:1950-1959
.
(29 April 2021)
Original Article on Radiotherapy in Thoracic Malignancies1
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Translational Lung Cancer Research
2021;
10
(4)
:1960-1968
.
(29 April 2021)
Review Article on Radiotherapy in Thoracic Malignancies1
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1969-1982
.
(29 April 2021)
Challenges in the target volume definition of lung cancer radiotherapy
Translational Lung Cancer Research
2021;
10
(4)
:1983-1998
.
(29 April 2021)
Evolving target volume concepts in locally advanced non-small cell lung cancer
Translational Lung Cancer Research
2021;
10
(4)
:1999-2010
.
(29 April 2021)
Tumour motion management in lung cancer: a narrative review
Translational Lung Cancer Research
2021;
10
(4)
:2011-2017
.
(29 April 2021)
Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
Translational Lung Cancer Research
2021;
10
(4)
:2018-2031
.
(29 April 2021)
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
Translational Lung Cancer Research
2021;
10
(4)
:2032-2047
.
(29 April 2021)
An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
Translational Lung Cancer Research
2021;
10
(4)
:2048-2058
.
(29 April 2021)
Thoracic radiotherapy in small cell lung cancer—a narrative review
Translational Lung Cancer Research
2021;
10
(4)
:2059-2070
.
(29 April 2021)
Prophylactic cranial irradiation in SCLC
Translational Lung Cancer Research
2021;
10
(4)
:2071-2078
.
(29 April 2021)
Controversies in the role of radiotherapy in pleural mesothelioma
Translational Lung Cancer Research
2021;
10
(4)
:2079-2087
.
(29 April 2021)
Radiotherapy for thymic epithelial tumours: a review
Translational Lung Cancer Research
2021;
10
(4)
:2088-2100
.
(29 April 2021)
Erratum
Erratum to latest CT technologies in lung cancer screening: protocols and radiation dose reduction
Translational Lung Cancer Research
2021;
10
(4)
:2101-2102
.
(29 April 2021)
Disclosure:
1. The series “Radiotherapy in Thoracic Malignancies” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Jacek Jassem and Rafał Dziadziuszko served as the unpaid Guest Editors for the series.
